Alto Neuroscience ANRO Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Alto Neuroscience in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alto Neuroscience's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Alto Neuroscience's common stock, shares issued (in shares)?
- Alto Neuroscience (ANRO) reported common stock, shares issued (in shares) of $35.05M in Q1 2026.
- How has Alto Neuroscience's common stock, shares issued (in shares) changed year-over-year?
- Alto Neuroscience's common stock, shares issued (in shares) increased by 29.5% year-over-year, from $27.07M to $35.05M.
- What is the long-term trend for Alto Neuroscience's common stock, shares issued (in shares)?
- Over 2 years (2023 to 2025), Alto Neuroscience's common stock, shares issued (in shares) has grown at a 188.6% compound annual growth rate (CAGR), from $3.83M to $31.92M.